Smartleaf Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.71K Hold
211
﹤0.01% 2558
2026
Q1
$11.3K Sell
211
-91
-30% -$4.33K ﹤0.01% 2266
2025
Q4
$11.3K Hold
302
﹤0.01% 2341
2025
Q3
$11.8K Buy
302
+158
+110% +$5.22K ﹤0.01% 2044
2025
Q2
$3.69K Sell
144
-191
-57% -$4.17K ﹤0.01% 2140
2025
Q1
$7.19K Buy
335
+130
+63% +$2.9K ﹤0.01% 2058
2024
Q4
$4.3K Buy
205
+29
+16% +$671 ﹤0.01% 2301
2024
Q3
$3.88K Buy
176
+81
+85% +$1.56K ﹤0.01% 2233
2024
Q2
$1.63K Buy
+95
New +$1.53K ﹤0.01% 2296

Other funds holding PAHC

Smartleaf Asset Management's PAHC Position: Q2 2026 in Review

Smartleaf Asset Management held its Phibro Animal Health (PAHC) position steady in Q2 2026 at 211 shares worth $6.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

Smartleaf Asset Management first reported a position in PAHC in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.8K in Q3 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Smartleaf Asset Management held 211 shares of Phibro Animal Health worth $6.71K as of Q2 2026.
  • Smartleaf Asset Management left its Phibro Animal Health share count unchanged in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2558 holding.
  • Smartleaf Asset Management first reported a position in Phibro Animal Health in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Phibro Animal Health position peaked at $11.8K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.